The dermatology imaging devices market has seen considerable growth due to a variety of factors.
• In recent years, there has been a rapid expansion in the market size of dermatology imaging devices. The market is projected to escalate from $2.18 billion in 2024 to $2.45 billion in 2025, with an impressive compound annual growth rate (CAGR) of 12.1%.
This significant growth in the historic period is attributable to various factors such as the rising incidence of skin disorders, increase in the elderly population, surge in demand for non-invasive procedures, increase in cosmetic dermatology procedures, and the evolution of the telemedicine landscape.
The dermatology imaging devices market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the dermatology imaging devices market is poised for a swift expansion, projected to reach $3.82 billion in 2029, with an 11.8% compound annual growth rate (CAGR). Factors contributing to this anticipated growth include the incorporation of artificial intelligence in dermatology imaging, increased public consciousness about aesthetic procedures, fusion of technology with health records, improved recognition and early detection of dermatological concerns, as well as the emergence of home-friendly dermatology remedies. Leading trends into this forecast period encompass wearable dermatology imaging devices, bespoke treatment options, advancements in 3D imaging technology, emphasis on preventative dermatology and continuing miniaturization of imaging technology.
Growing instances of skin-related issues are anticipated to drive the expansion of the dermatology imaging devices market in the future. Skin conditions encompass a variety of medical complications that impact the skin's look, feel, and functionality, such as dermatitis, acne, eczema, psoriasis, and skin cancer. The rise in these conditions can be attributed to numerous factors, notably disturbances in the skin microbiome, which is a myriad of microorganisms that inhabit the skin's exterior. Dermatology imaging tools are employed to observe and identify diverse skin conditions by generating detailed images of the skin's surface, thereby aiding dermatologists in precise evaluations and treatment strategizing. For instance, as per the US-based National Cancer Institute (NCI), the City of Hope documented in May 2023 that melanoma currently represents about 5.5% of yearly cancer diagnoses, equivalent to roughly 97,000 occurrences. By 2030, this percentage is estimated to increase to 7.1%, equating to nearly 151,000 annual occurrences. Consequently, the escalating prevalence of skin conditions is bolstering the expansion of the dermatology imaging devices market.
The dermatology imaging devices market covered in this report is segmented –
1) By Modality: Digital Photographic Imaging, Optical Coherence Tomography (OCT), Dermatoscope, High Frequency Ultrasound, Other Modalities
2) By Application: Skin Cancers, Inflammatory Dermatoses, Plastic and Reconstructive Surgery, Other Applications
3) By End-Use: Hospitals, Dermatology Centers, Specialty Clinics
Subsegments:
1) By Digital Photographic Imaging: Standard Digital Cameras, High-Resolution Digital Cameras, 3D Imaging Systems
2) By Optical Coherence Tomography (OCT): Time-Domain OCT, Spectral-Domain OCT, Swept-Source OCT
3) By Dermatoscope: Handheld Dermatoscopes, Desktop Dermatoscopes
4) By High Frequency Ultrasound: Skin Ultrasound Systems, Multi-Frequency Ultrasound Devices
5) By Other Modalities: Confocal Microscopy, Magnetic Resonance Imaging (MRI) For Dermatology, Raman Spectroscopy
Major corporations in the dermatology imaging devices market are shifting their focus towards the creation of pioneering technologies, such as comprehensive hyperspectral imaging tools, to discern initial signs of skin diseases and correctly distinguish benign from malignant tissues. For example, Swift Medical, a Biotech company based in Canada, unveiled the Swift Ray 1, an all-encompassing hyperspectral imaging tool that syncs wirelessly with smartphone cameras in March 2022. This revolutionary device allows medical professionals to obtain extensive clinical data on skin and wound conditions through advanced imaging technologies like near-infrared and ultraviolet imaging. The Swift Ray 1, being compact and mobile, is suited for use in different settings and fosters equitable care by offering precise assessments regardless of skin color. It fits perfectly with Swift Medical's wound management software, improving clinical procedures and facilitating real-time wound healing tracking.
Major companies operating in the dermatology imaging devices market report are:
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• Stryker Corporation
• GE HealthCare Technologies Inc.
• PerkinElmer Inc.
• Carl Zeiss Meditec AG
• Barco NV
• e-con Systems Inc.
• Canfield Scientific Inc.
• Fujifilm VisualSonics Inc.
• Clarius Mobile Health Corp
• FotoFinder Systems GmbH
• Quantificare SA
• Courage+Khazaka electronic GmbH
• Navitar Inc.
• Cortex Technology ApS
• DRAMINSKI S. A.
• Michelson Diagnostics Ltd
• Caliber Imaging and Diagnosis Inc
• Bomtech Electronics Co. Ltd
• Emage Medical LLC
• MetaOptima Technology Inc.
• 3dMD LLC
• DermaSensor Inc.
• DermLite LLC
• ATYS MEDICAL S.A.S
• Dermspectra LLC
• Taberna Pro Medicum GmbH
• Macquarie Medical Systems Pty Limited
North America was the largest region in the dermatology imaging devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermatology imaging devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.